Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 137, Issue 5, Pages 782-794
Publisher
Wiley
Online
2016-01-29
DOI
10.1111/jnc.13553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology
- (2015) Marie-Victoire Guillot-Sestier et al. NEURON
- IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior
- (2015) Paramita Chakrabarty et al. NEURON
- HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation
- (2014) Ulrike Träger et al. BRAIN
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
- (2014) Manoj Kumar Mishra et al. Annals of Clinical and Translational Neurology
- The Role of the Immune System in Huntington’s Disease
- (2013) Gisa Ellrichmann et al. Clinical & Developmental Immunology
- A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease
- (2013) Han-Yun Hsiao et al. HUMAN MOLECULAR GENETICS
- Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
- (2013) M. Filippi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
- (2012) Wolfgang Brück et al. ACTA NEUROPATHOLOGICA
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Mutant huntingtin impairs immune cell migration in Huntington disease
- (2012) Wanda Kwan et al. JOURNAL OF CLINICAL INVESTIGATION
- Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease
- (2012) W. Kwan et al. JOURNAL OF NEUROSCIENCE
- Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease
- (2012) J. Bouchard et al. JOURNAL OF NEUROSCIENCE
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
- (2012) Ulf Schulze-Topphoff et al. PLoS One
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- Insight into the mechanism of laquinimod action
- (2011) W. Brück et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
- (2011) Gisa Ellrichmann et al. PLoS One
- Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging study
- (2010) Marios Politis et al. HUMAN BRAIN MAPPING
- Laquinimod suppress antigen presentation in relapsing–remitting multiple sclerosis: In-vitro high-throughput gene expression study
- (2010) M. Gurevich et al. JOURNAL OF NEUROIMMUNOLOGY
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- A futility study of minocycline in Huntington's disease
- (2010) Merit Cudkowicz MOVEMENT DISORDERS
- Oral laquinimod therapy in relapsing multiple sclerosis
- (2009) Jana Preiningerova EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
- (2008) Maria Björkqvist et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration
- (2007) Karine Palin et al. NEUROBIOLOGY OF DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now